Showing results (151-160 of 161) with videos related to

Sort By:
Pageof 17
British Journal of Haematology|April 13, 2024
Mixed histiocytic neoplasms: A multicentre series revealing diverse somatic mutations and responses to targeted therapyJoshua S Friedman, Benjamin H Durham, Anne S Reiner, et al.
Cell|June 25, 2021
Pharmacologic modulation of RNA splicing enhances anti-tumor immunitySydney X Lu, Emma De Neef, James D Thomas, et al.
The New England Journal of Medicine|February 23, 2022
Mechanisms of Resistance to Noncovalent Bruton's Tyrosine Kinase InhibitorsEric Wang, Xiaoli Mi, Meghan C Thompson, et al.
Open Forum Infectious Diseases|March 4, 2024
A Baker's Dozen of Top Antimicrobial Stewardship Intervention Publications in 2022Reagan K Barfield, Matthew L Brown, Benjamin Albrecht, et al.
Blood Advances|May 2, 2025
NTRK1-rearranged histiocytosis: clinicopathologic and molecular featuresRivers Fragneau, Sylvie Fraitag, Paul G Kemps, et al.
Nature Medicine|November 27, 2019
Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasmsBenjamin H Durham, Estibaliz Lopez Rodrigo, Jennifer Picarsic, et al.
Nature Medicine|November 15, 2016
DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodelingOlga A Guryanova, Kaitlyn Shank, Barbara Spitzer, et al.
Cancer Cell|October 24, 2025
RAF-independent MEK mutations drive refractory histiocytic neoplasms but respond to ERK inhibitionEli L Diamond, Jean-Francois Emile, Takeshi Fujino, et al.
Cancer Discovery|November 15, 2015
Diverse and Targetable Kinase Alterations Drive Histiocytic NeoplasmsEli L Diamond, Benjamin H Durham, Julien Haroche, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 2, 2023
Overcoming Barriers to Tumor Genomic Profiling through Direct-to-Patient OutreachSeyram A Doe-Tetteh, Sabrina Y Camp, Dalicia Reales, et al.
Pageof 17